Biocyte Pharma
FDA import alert and refusal historyLahore, PakistanFEI 3015341517
Recorded by FDA as BIOCYTE PHARMA
As of October 26, 2026, Biocyte Pharma is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on June 3, 2019, most often for required label information not in english (NO ENGLISH).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Tea, green · NO ENGLISH
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Biocyte Pharma
1 record, newest first. Each line links to the FDA page it came from.
2019
- Import refusalRefused, Tea, greenNO ENGLISHEntry SCS-4781192-3Source
Refusal charges, in plain English
- NO ENGLISH1 refused line
Required label information not in English
Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.
Questions about Biocyte Pharma
- Is Biocyte Pharma on an FDA import alert?
- No listing for Biocyte Pharma appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Pakistan page.
- Has FDA refused shipments from Biocyte Pharma?
- Yes. FDA refused 1 shipment line from Biocyte Pharma on June 3, 2019. The most recent, on June 3, 2019, was tea, green, charged as NO ENGLISH (required label information not in english).
- Why did FDA refuse Biocyte Pharma's shipments?
- The most frequent charge is NO ENGLISH (required label information not in english, 1 line).
- What is Biocyte Pharma's FEI number?
- Biocyte Pharma's FDA Establishment Identifier (FEI) is 3015341517.
Buying from Biocyte Pharma?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.